Statements of Operations
Ended March 31,
Research and development costs
General and administrative expenses
Depreciation and amortization
Total operating expenses
Nonoperating income (expense):
Warrant issuance and modification expense
Gain (loss) from change in fair value adjustment of warrant obligations
Total nonoperating income (expense)
Net loss attributable to common shareholders
Net loss per share - basic and diluted
Weighted average common shares outstanding - basic and diluted
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All